Giant cell arteritis update

A G Neff1, E M Greifenstein

  • 1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL 33136, USA.

Insights

Giant cell arteritis (GCA) is a medical emergency affecting large arteries. Prompt diagnosis and treatment are vital to prevent vision loss and other severe complications.

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Systemic Vasculitis

Background:

  • Giant cell arteritis (GCA) is a systemic inflammatory disease affecting medium and large arteries.
  • It presents a significant risk for irreversible vision loss and other systemic complications if not treated promptly.
  • Early recognition is crucial as prognosis for already affected vision is typically poor.

Purpose of the Study:

  • To review the key aspects of diagnosis for Giant cell arteritis.
  • To outline the recommended management strategies for GCA.
  • To discuss potential complications associated with GCA and its treatment.

Main Methods:

  • Review of existing literature on Giant cell arteritis.
  • Synthesis of information regarding clinical manifestations, diagnostic criteria, and treatment protocols.
  • Analysis of complications and their prevention.

Main Results:

  • GCA requires immediate intervention to prevent severe outcomes like blindness.
  • Knowledge of GCA's varied presentations aids in early diagnosis.
  • Effective management strategies can prevent most complications.

Conclusions:

  • Giant cell arteritis is a critical condition necessitating urgent medical attention.
  • Timely diagnosis and treatment are paramount in preventing irreversible damage.
  • Understanding GCA manifestations is key for effective patient outcomes.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...